三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
主要ROS1/ALK/TRK小分子靶向药1L治疗ROS1+NSCLC临床数据对比
主要ROS1/ALK/TRK小分子靶向药1L治疗ROS1+NSCLC临床数据对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:74KB
图片尺寸:2298*301
同报告图片
/
4
5Lul5LiL5piv5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yaCgp8IOmAmueUqOWQjSAgICAgICAgICAgfCDnlJ/kuqfljoLlrrYgICAgICAgfCDnvo7lm73noJTlj5Hov5vlsZUgfCDkuK3lm73noJTlj5Hov5vlsZUgfCDmoLfmnKzph48obikgfCBPUlIgICB8IFBGUyjmnIgpICAgICAgIHwgM+e6p+S7peS4ilRSQUUgfAp8LS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18CnwgUmVwb3RyZWN0aW5pYiAgICB8IFR1cm5pbmcgcG9pbnQgIHwgUHJlLU5EQSAgICAgIHwgMuacn+azqOWGjOS4tOW6iiAgIHwgNzEgICAgICAgIHwgNzkuMCUgIHwgPjE45Liq5pyIICAgICAgIHwgPDEwJSAgICAgICAgfAp8IOaBqeabsuabv+WwvCAgICAgICAgIHwg572X5rCPICAgICAgICAgICB8IDE55bm06I635om55LiK5biCICB8IDIy5bm06I635om55LiK5biCICAgfCA2NyAgICAgICAgfCA2OC43JSAgfCAxNy43ICAgICAgICAgIHwgMzUlICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaVHVybmluZyBQb2ludOWMu+eWl+WFrOWPuOWFrOWRiu+8jDIwMjIgV0NMQ++8jOWNjuazsOeglOeptg==
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
5aW955qE77yM5Lul5LiL5piv5LiA5Liq5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv55Sf5oiQ55qE6KGo5qC877yaCnwg6KGM5p2D5om55qyhIHwg6KGM5p2D5pyfIHwg5Y+v6KGM5p2D5pWw6YeP5Y2g5q+UIHwg5YWs5Y+45Lia57up6ICD5qC46KaB5rGCIHwKfCA6LS06IHwgOi0tOiB8IDotLTogfCA6LS06IHwKfCAxIHwg562J5b6F5pyf5bGK5ruh5LmL5pel6LW355qE56ysMeS4quS6pOaYk+aXpeiHszEy5Liq5pyI5YaF55qE5pyA5ZCO5LiA5Liq5Lqk5piT5pelIHwgMzQlIHwg5Lul5LiL55uu5qCH5YWo6YOo5a6M5oiQ5pa55Y+v5YWo6YOo6KGM5p2D77yM6Iul5Lu75LiA55uu5qCH5pyq5a6M5oiQ77yM5YiZ6K+l6KGM5p2D5pyf5YaF5YWo6YOo5pyf5p2D6Ieq5Yqo5aSx5pWI77yaMS7lrozmiJDkuIrluILkuJTku47kuIrluILml6Xotbfoh7PokaPkuovkvJrlrqHorq7ooYzmnYPmnaHku7bml6XliY3kuIDml6XnmoTlubPlnYfluILlgLzovr7liLDkurrmsJHluIExMDDkur/lhYPvvJsyLuaIquiHs+iRo+S6i+S8muWuoeiuruihjOadg+adoeS7tuS5i+aXpe+8jDHkuKrkuqflk4HmiJbpgILlupTnl4flpITkuo7lhbPplK7mgKfmiJZJSUnmnJ/kuLTluoror5XpqozpmLbmrrXvvJszLuaIquiHs+iRo+S6i+S8muWuoeiuruihjOadg+adoeS7tuS5i+aXpe+8jDHkuKrkuqflk4HmiJbpgILlupTnl4fnmoTmpoLlv7Xpqozor4Hor5Xpqozlj5blvpfnp6/mnoHnu5PmnpzjgIIgfAp8IDIgfCDnrYnlvoXmnJ/lsYrmu6HkuYvml6XotbcxMuS4quaciOWQjueahOesrDHkuKrkuqTmmJPml6Xoh7MyNOS4quaciOWGheeahOacgOWQjuS4gOS4quS6pOaYk+aXpSB8IDMzJSB8IOS7peS4i+S7u+S4gOebruagh+WujOaIkO+8jOWPr+ihjOadg+ebuOW6lOavlOS+i++8mjEu6KGM5p2D5pel5omA5Zyo5bm05bqm55qEMeaciDHml6Xoh7PokaPkuovkvJrlrqHorq7ooYzmnYPmnaHku7bml6XnmoTliY3kuIDlpKnvvIzlubPlnYfluILlgLzovr7liLDkurrmsJHluIExMzDkur/lhYPvvIjoi6XlrozmiJDlj6/ooYzmnYMyNSXvvInvvJsyLuaIquiHs+iRo+S6i+S8muWuoeiuruihjOadg+adoeS7tuS5i+aXpe+8jDHpobnlhbPplK7mgKfmiJZJSUnmnJ/kuLTluoror5Xpqozlj5blvpfnp6/mnoHnu5PmnpzvvIjoi6XlrozmiJDlj6/ooYzmnYM1MCXvvInvvJszLuaIquiHs+iRo+S6i+S8muWuoeiuruihjOadg+adoeS7tuS5i+aXpe+8jDHkuKrkuqflk4HmiJbpgILlupTnl4flpITkuo7lhbPplK7mgKfmiJZJSUnmnJ/kuLTluoror5XpqozpmLbmrrXkuJQx5Liq5Lqn5ZOB5oiW6YCC5bqU55eH55qE5qaC5b+16aqM6K+B6K+V6aqM5oiWSUnmnJ/kuLTluoror5Xpqozlj5blvpfnp6/mnoHnu5PmnpzvvIjoi6XlrozmiJDlj6/ooYzmnYMyNSXvvInjgIIgfAp8IDMgfCDnrYnlvoXmnJ/lsYrmu6HkuYvml6XotbcyNOS4quaciOWQjueahOesrDHkuKrkuqTmmJPml6Xoh7MzNuS4quaciOWGheeahOacgOWQjuS4gOS4quS6pOaYk+aXpSB8IDMzJSB8IOS7peS4i+S7u+S4gOebruagh+WujOaIkO+8jOWPr+ihjOadg+ebuOW6lOavlOS+i++8mjEu6KGM5p2D5pel5omA5Zyo5bm05bqm55qEMeaciDHml6Xoh7PokaPkuovkvJrlrqHorq7ooYzmnYPmnaHku7bml6XnmoTliY3kuIDlpKnvvIzlubPlnYfluILlgLzovr7liLDkurrmsJHluIExNjnkur/lhYPvvIjoi6XlrozmiJDlj6/ooYzmnYMyNSXvvInvvJsyLuaIquiHs+iRo+S6i+S8muWuoeiuruihjOadg+adoeS7tuS5i+aXpe+8jOWFrOWPuOaPkOS6pOS4gOmhueaWsOiNr+azqOWGjOeUs+ivt++8iOiLpeWujOaIkOWPr+ihjOadgzUwJe+8ie+8mzMu5oiq6Iez6JGj5LqL5Lya5a6h6K6u6KGM5p2D5p2h5Lu25LmL5pel77yMMemhueWFs+mUruaAp+aIlklJSeacn+S4tOW6iuivlemqjOWPluW+l+enr+aegee7k+aenOaIljHkuKrkuqflk4HmiJbpgILlupTnl4fnmoTmpoLlv7Xpqozor4Hor5XpqozmiJZJSeacn+S4tOW6iuivlemqjOWPluW+l+enr+aegee7k+aenO+8iOiLpeWujOaIkOWPr+ihjOadgzI1Je+8ieOAgiB8CgrotYTmlpnmnaXmupDvvJrov6rlk7LljLvoja/mi5vogqHor7TmmI7kuabvvIzljY7ms7DnoJTnqbY=
所属报告:
迪哲医药-具备全球竞争力的创新型biotech-221205(39页).pdf
打包全文图表
相关数据
ADC联合IO单抗治疗一线NSCLC全球三期研究启动时间
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
收藏
行业数据
2026-07-14
原图定位
查看详情
KRASG12C一线治疗NSCLC竞争格局(截至2026-6-25)
收藏
竞争格局
2026-07-01
原图定位
查看详情
全球KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
中国KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
SHR-A2009用于EGFR突变型NSCLC的1期临床研究结果
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
收藏
行业数据
2026-05-28
原图定位
查看详情
SHR-A2009用于一线NSCLC患者的研究结果
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
收藏
行业数据
2026-05-28
原图定位
查看详情
PD(L)1*VEGF双抗单药针对一线NSCLC数据汇总
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
收藏
行业数据
2026-03-13
原图定位
查看详情
各药物针对IO耐药NSCLC临床数据汇总
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
收藏
行业数据
2026-03-13
原图定位
查看详情
驱动基因阴性晚期NSCLC治疗格局
收藏
竞争格局
2026-02-24
原图定位
查看详情
NSCLC1L全球竞争格局AK112BNT327707
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
收藏
竞争格局
2026-01-28
原图定位
查看详情
SI-B001针对PD-(L1)抑制剂治疗失败的野生型NSCLC的mPFS数据
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
收藏
行业数据
2025-12-26
原图定位
查看详情
图表4国NSCLC驱动基因谱
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
收藏
行业数据
2025-12-03
原图定位
查看详情
图表20EGFR耐药后NSCLC试验数据比
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
收藏
行业数据
2025-12-03
原图定位
查看详情
图表11KRAS在肺癌(NSCLC)、结直肠癌(CRC)、胰腺癌(PDAC)突变情况
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
收藏
行业数据
2025-11-21
原图定位
查看详情
NSCLC1L全球竞争格局AK112BNT327707
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
收藏
竞争格局
2025-11-18
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
对外授权可期,有望实现产品出海 对标 Turning Point 医疗 BIC 产品 Repotrectinib,前景可期。4M22,BMS 原计划以 7亿美金首付款+4.2 亿美金开发里程碑+3.75 亿美金销售里程碑获得 Turning Point 核心资产Repotrectinib(双方共同开发美国市场并平分利润,BMS 独自开发美国外市场),后经多次 谈判,最终 于 6M22以 41亿美元现金收购Turning Point。 Repotrectinib为ROS1/ALK/NTRK靶点 BIC 小分子抑制剂,基于在 ROS1+ NSCLC 患者(肺癌中突变率约 2%)中出众的疗效及安全性(1L 治疗 ORR 79%,18 个月 PFS 率 72%,三级以上 TRAE<10%;克唑替尼耐药患者 ORR 59%),先后获 FDA 授予 3 项突破疗法认证、1 项孤儿药认证和 4 项快速通道。Turning Point 已于 6M22 与 FDA 召开 pre-NDA 会议,预计 23 年获 FDA 批准上市。
行业数据
原图定位
当前图表所属:
迪哲医药-具备全球竞争力的创新型biotech-221205(39页).pdf
舒沃替尼(DZD9008):选择性及靶向性优于同类小分子竞品
舒沃替尼(DZD9008)与竞品的疗效对比
迪哲医药:收入利润及研发费用
迪哲医药:2020年员工股份期权计划
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》